N80.221

Clinical Causes: Genetic predisposition that increases susceptibility to endometrial tissue growth outside the uterus. Retrograde menstruation, where menstrual blood flows backward into the pelvic cavity and deposits endometrial cells on pelvic organs. Hormonal factors that promote the growth and maintenance of endometrial tissue outside the uterine cavity. Environmental influences, including exposure to certain chemicals that may affect hormonal balance. Immune system dysfunction that allows endometrial tissue to implant and grow outside the uterus.

Key Symptoms: Pelvic pain, often worsening during menstruation. Pain during intercourse (dyspareunia). Unusual menstrual bleeding, such as heavier periods or irregular cycles. Infertility or difficulty conceiving. Lower back pain and discomfort in the abdominal area. Pain or tenderness specifically in the area of the right fallopian tube, which may be aggravated by movement.

Diagnosis Path: Pelvic examination to identify tenderness, nodules, or abnormalities. Ultrasound imaging, which can reveal cysts or masses related to endometrial tissue. Magnetic Resonance Imaging (MRI), offering detailed images to assess the extent and depth of tissue invasion. Laparoscopy, a minimally invasive surgical procedure, considered the gold standard for definitive diagnosis, allowing direct visualization and biopsy of endometrial implants.

Treatment Protocols: Hormonal therapy to suppress endometrial tissue growth, such as birth control pills, GnRH analogs, or progestins. Pain management with non-steroidal anti-inflammatory drugs (NSAIDs). Surgical intervention to remove endometrial implants, cysts, and scar tissue, especially if pain is severe or fertility is affected. Assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), for those experiencing infertility due to the condition. Lifestyle changes, including dietary modifications and physical therapy, to manage symptoms more effectively.